Julien Flament1, Franoise Geffroy1, Christelle Mdina2, Caroline Robic2, Philippe Robert2, Marc Port2, Gilles Bloch1, Denis Le Bihan1, Franck Lethimonnier1
1CEA/DSV/IBM/NeuroSpin, Gif-sur-Yvette, France; 2Guerbet Research, Roissy-Charles de Gaulle, France
LipoCEST are promising contrast agents for molecular imaging which can be functionalized to target specific biomarkers. Although in vivo detection is complicated by to endogenous MT effects, several studies have already shown feasibility. Still, quantification remains very challenging. Here, we used a 4-pools model which takes into account both endogenous and exogenous MTRasym effects as well as field inhomogeneities in order to establish in vivo quantitative maps. This model was evaluated in a tumor mouse brain model with a functionalized RGD-lipoCEST which targets α ν β 3 integrins expressed during tumor angiogenesis.